2023-509009-59-00撤回1 期
Psilocybin's effects on anhedonia
适应症
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 入组人数
- 85
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Division of General Psychiatry
Scientific
Medical University of Vienna
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Psilocybin's effects on anhedoniaMedDRA version: 23.0Level: LLTClassification code: 10083288Term: Clinical depression Class: 10037175MedDRA version: 24.0Level: LLTClassification code: 10056941Term: MRI brain Class: 10022891MedDRA version: 20.0Level: PTClassification code: 10002511Term: Anhedonia Class: 100000004873MedDRA version: 20.0Level: LLTClassification code: 10027942Term: Mood depression Class: 10037175MedDRA version: 21.1Level: PTClassification code: 10054976Term: Antidepressant therapy Class: 100000004865Major Depressive DisorderCTIS2023-509009-59-00Medical University of Vienna85
进行中（未招募）
2 期
Psilocybin for Treatment-Resistant DepressionAnhedoniaTreatment Resistant DepressionMajor Depressive DisorderNCT06230757University of Colorado, Denver40
已完成
1 期
PsiConnect: Brain Connectivity and Context under PsilocybinACTRN12621001375842Monash University60
进行中（未招募）
1 期
The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant DepressioTreatment-Resistant Depression (P-TRD)MedDRA version: 21.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873MedDRA version: 21.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873EUCTR2017-003288-36-CZCOMPASS Pathfinder, Limited216
进行中（未招募）
1 期
The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant DepressioEUCTR2017-003288-36-PTCOMPASS Pathfinder Limited216